NORCROSS, Ga.--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB: ARGA) or "Auriga", a specialty pharmaceutical company with products for the treatment of acute respiratory diseases, dermatological conditions, and Xerostomia, announced today that it has expanded its sales force to 56 representatives from just 9 less than six months ago. The sales force distributes the Company’s rapidly-growing innovative line of pharmaceutical products including the Extendryl® line of cough and cold products, the newly acquired Levall® product line common cold remedy prescription drug products and the Aquoral™ line, a prescription-only product designed to treat the widespread condition of Xerostomia (or dry mouth).
